‘What’s happening with proposals for a WTO waiver of COVID-related IP?’

“If COVID-19 were a pandemic movie, we’d be very close to the end since we’ve identified several excellent vaccines; the conventional biomedical innovation narrative often ends with the product being fully developed. But we’ve still got a long way to go with COVID-19, and the biggest challenge is getting the vaccines to billions more people (and getting them to take the vaccines, but that’s a separate topic). Only 0.3% of global doses have been administered in low-income countries, many of which are confronting severe outbreaks …” (more)

Nicholson Price, Rachel Sachs, Jacob S Sherkow and Lisa Larrimore Ouellette, Written Description, 30 July.

(Visited 28 times, 1 visits today)

Leave a Reply